help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0243
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/8/3034    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randolph, J. F.
Right arrow Articles by Yosef, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randolph, J. F., Jr.
Right arrow Articles by Yosef, M.
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 8 3034-3040
Copyright © 2006 by The Endocrine Society

The Value of Follicle-Stimulating Hormone Concentration and Clinical Findings as Markers of the Late Menopausal Transition

John F. Randolph, Jr., Sybil Crawford, Lorraine Dennerstein, Kevin Cain1, Siobán D. Harlow1, Roderick Little1, Ellen S. Mitchell1, Bin Nan1, John Taffe1 and Matheos Yosef1

University of Michigan (J.F.R., S.D.H., R.L., B.N., M.Y.), Ann Arbor, Michigan 48109; University of Massachusetts (S.C.), Worcester, Massachusetts 01655; University of Melbourne (L.D.), Victoria 3050, Australia; University of Washington (K.C., E.S.M.), Seattle, Washington 98195; and Monash University (J.T.), Victoria 3168, Australia

Address all correspondence and requests for reprints to: John F. Randolph, Jr., M.D., L4228 Women’s Hospital, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-0276. E-mail: jfrandol{at}med.umich.edu.

Context: The Stages of Reproductive Aging Workshop proposed bleeding and hormonal criteria for the menopausal transition, but operational definitions of hormone parameters were not specified.

Objective: This paper investigates the longitudinal relationship of annual serum FSH levels with four proposed bleeding criteria for the late menopausal transition in two cohort studies. The goal is to provide empirically based guidance regarding application of hormonal criteria that may be optimal for widespread application in clinical and research settings for assessing menopausal stage.

Design/Setting: Prospective menstrual calendar and annual serum FSH data were collected from two population-based cohort studies: the Melbourne Women’s Midlife Health Project and the Study of Women’s Health Across the Nation.

Participants: Participants in the study were 193 Melbourne Women’s Midlife Health Project and 2223 Study of Women’s Health Across the Nation women aged 42–57 yr at baseline who contributed 10 or more menstrual cycles and at least one annual serum FSH value.

Main Outcome Measure(s): Association between bleeding criteria for the late menopausal transition and FSH was a main outcome measure. Associations of bleeding criteria, FSH, and hot flashes with the final menstrual period were also measured.

Results: A single FSH measure is an independent marker of the late menopausal transition, but FSH concentrations are less predictive of menopausal stage than any of four proposed bleeding criteria. Criterion FSH values for the late transition are similar across both studies. Experience of hot flashes adds no information in the presence of hormonal and bleeding criteria.

Conclusions: An annual serum FSH concentration of 40 IU/liter could be incorporated, in conjunction with bleeding markers, into the Stages of Reproductive Aging Workshop paradigm for markers of the late menopausal transition.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. G. Hudson, G. L. Gierach, F. Modugno, J. Simpson, J. W. Wilson, R. W. Evans, V. G. Vogel, and J. L. Weissfeld
Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 680 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. E. Hale, X. Zhao, C. L. Hughes, H. G. Burger, D. M. Robertson, and I. S. Fraser
Endocrine Features of Menstrual Cycles in Middle and Late Reproductive Age and the Menopausal Transition Classified According to the Staging of Reproductive Aging Workshop (STRAW) Staging System
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3060 - 3067.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Harlow, K. Cain, S. Crawford, L. Dennerstein, R. Little, E. S. Mitchell, B. Nan, J. F. Randolph Jr., J. Taffe, and M. Yosef
Evaluation of Four Proposed Bleeding Criteria for the Onset of Late Menopausal Transition
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3432 - 3438.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society